Primary record
(2R,3R,4S,5R,6R)-2-[(E,2S,3R)-2-amino-3-hydroxy-octadec-4-enoxy]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol
- 库存
- 5,006 克
- 纯度
- 99.1 %
- CAS
- 2238-90-6
化合物标识与属性
- CAS
- 2238-90-6
- PubChem CID
- 5280458
- SMILES
- CCCCCCCCCCCCC/C=C/[C@H]([C@H](CO[C@H]1[C@@H]([C@H]([C@H]([C@H](O1)CO)O)O)O)N)O
- Canonical SMILES
- CCCCCCCCCCCCC/C=C/[C@@H](O)[C@@H](N)CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O
名称与同义词
- PSYCHOSINE
- Galactosylsphingosine
- erythro-Psychosine
- beta-psychosine
- Sphingosine galactoside
- O-Galactosylsphingosine
- 2238-90-6
- 1-beta-D-galactosphingosine
- 1-beta-D-Galactosylsphingosine
- Galactoside, Sphingosine
- 1-Galactosyl sphingosine
- b-D-Galactosylsphingosine
- RefChem:177063
- CHEBI:16874
- D04ICS
- Epitope ID:151082
- SCHEMBL242696
- AC1NQX21
- BG5A25U68L
- Psychosine from bovine brain
- C24H47NO7
- 1-|A-D-Galactosylsphingosine
- GTPL5548
- orb1705165
- ?-Galactosyl erythro-Sphingosine
- 1-beta-D-galactosyl-sphing-4-enine
- 1-O-beta-D-galactosylsphingosine
- DTXSID60896981
- |A-Galactosyl erythro-Sphingosine
- HHJTWTPUPVQKNA-PIIMIWFASA-N
- MFCD07374280
- DTXCID001326409
- DTXSID101372293
- 1-O-beta-D-galactopyranosylsphingosine
- Alpha-Galactosyl erythro-Sphingosine
- ZINC8217367
- C24-H47-N-O7
- b-D-Galactosylsphingosine - Synthetic
- D-galactosyl-beta1-1'-D-erythro-sphingosine
- AKOS037645023
- CID5280458
- MG44866
- D-galactosyl-|A1-1'-D-erythro-sphingosine
- AS-56228
- DA-57203
- J39.570F
- D-galactosyl-|A1-1-D-erythro-sphingosine
- HY-136490
- CS-0129786
- J1.822.469K
- C01747
- G91336
- 2-amino-3-hydroxy-4-octadecenyl Galactopyranoside
- (2R,3R,4S,5R,6R)-2-[(E,2S,3R)-2-amino-3-hydroxyoctadec-4-enoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
- A1201805
- Galactopyranoside, 2-amino-3-hydroxy-4-octadecenyl
- Q25106489
- beta-D-Galactopyranoside, 2-amino-3-hydroxy-4-octadecenyl, (R-(R*,S*-(E)))-
- Psychosine from bovine brain, lyophilized powder, >=98% (TLC)
- (2S,3R)-1-(beta-D-Galactopyranosyloxy)-2-amino-4-octadecene-3-ol
- (2R,3R,4S,5R,6R)-2-[(E,2S,3R)-2-amino-3-hydroxy-octadec-4-enoxy]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol
- (2S,3R,4E)-1-(beta-D-Galactopyranosyloxy)-2-amino-4-octadecene-3-ol
- (2S,3R,4E)-2-amino-1-(beta-D-galactopyranosyloxy)-3-hydroxyoctadec-4-ene
- (2S,3R,4E)-2-Amino-3-hydroxy-4-octadecen-1-yl |_-D-galactopyranoside
- (2S,3R,4E)-2-Amino-3-hydroxy-4-octadecen-1-yl |A-D-Galactopyranoside
- (2S,3R,4E)-2-Amino-3-hydroxy-4-octadecen-1-yl a-D-Galactopyranoside;
- (2S,3R,4E)-2-Amino-3-hydroxy-4-octadecen-1-yl beta-D-galactopyranoside
- (2S,3R,4E)-2-amino-3-hydroxyoctadec-4-en-1-yl beta-D-galactopyranoside
- (E)-DL-erythro-b-D-2-amino-3-hydroxy-4-octadecenyl Galactopyranoside
- (E)-DL-erythro-beta-delta-2-amino-3-hydroxy-4-octadecenyl Galactopyranoside
- [(2S,3R,4E)-2-Amino-3-hydroxy-4-octadecenyl]beta-D-galactopyranoside
- [R-[R*,S*-(E)]]-2-amino-3-hydroxy-4-octadecenyl b-D-Galactopyranoside
- beta-D-Galactopyranoside, (2S,3R,4E)-2-amino-3-hydroxy-4-octadecen-1-yl
- beta-D-Galactopyranoside, (2S,3R,4E)-2-amino-3-hydroxy-4-octadecenyl
- Galactopyranoside, 2-amino-3-hydroxy-4-octadecenyl, (E)-DL-erythro-beta-D-
- [R-[R*,S*-(E)]]-2-amino-3-hydroxy-4-octadecenyl b-delta-Galactopyranoside
- B-D-GALACTOPYRANOSIDE,(2S,3R,4E)-2-AMINO-3-HYDROXY-4-OCTADECEN-1-YL
- (2R,3R,4S,5R,6R)-2-((E,2S,3R)-2-amino-3-hydroxyoctadec-4-enoxy)-6-(hydroxymethyl)oxane-3,4,5-triol
- (2R,3R,4S,5R,6R)-2-[(E)-2-amino-3-hydroxyoctadec-4-enoxy]-6-(hydroxymethyl)oxane-3,4,5-triol
- (2R,3R,4S,5R,6R)-2-{[(2S,3R)-2-amino-3-hydroxyoctadec-4-en-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
- (2R,3R,4S,5R,6R)-2-{[(2S,3R,4E)-2-amino-3-hydroxyoctadec-4-en-1-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol
- 223800-33-7
- 4-[4-[2,6-bis(methylsulfanylmethyl)pyridin-4-yl]phenyl]-2,6-bis(methylsulfanylmethyl)pyridine